These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4113143

  • 1. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Drewinko B, Novak JK, Barranco SC.
    Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC, DeVita VT, Serpick AA, Canellos GP.
    N Engl J Med; 1971 Aug 26; 285(9):475-9. PubMed ID: 5558887
    [No Abstract] [Full Text] [Related]

  • 3. Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962).
    Bonmassar E, Cudkowicz G, Vadlamudi S, Goldin A.
    Cancer Res; 1970 Oct 26; 30(10):2538-42. PubMed ID: 5474176
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR, Ausman JI, Rall DP.
    Cancer Res; 1970 Sep 26; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract] [Full Text] [Related]

  • 5. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun 26; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract] [Full Text] [Related]

  • 6. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun 26; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract] [Full Text] [Related]

  • 7. Effects of cytosine arabinoside and 1,3-bis(2-chloroethyl)-1-nitrosourea on human glial tumor cells.
    Chen TT, Mealey J.
    Cancer Res; 1972 Mar 26; 32(3):558-64. PubMed ID: 4334413
    [No Abstract] [Full Text] [Related]

  • 8. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW, Humphrey EW.
    Cancer Chemother Rep; 1972 Feb 26; 56(1):53-9. PubMed ID: 5030809
    [No Abstract] [Full Text] [Related]

  • 9. B.C.N.U. (1,3-bis (2-chloroethyl) -1-nitrosourea) in the treatment of advanced Hodgkin's disease.
    Cipriani D, Strinchini A.
    Lancet; 1972 Jun 17; 1(7764):1345. PubMed ID: 4113442
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of mycosis fungoides with topical nitrosourea compounds.
    Zackheim HS.
    Arch Dermatol; 1972 Aug 17; 106(2):177-82. PubMed ID: 5048217
    [No Abstract] [Full Text] [Related]

  • 11. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB, Falkson HC, Falkson G.
    Cancer Chemother Rep; 1970 Oct 17; 54(5):347-59. PubMed ID: 5514624
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
    Drewinko B, Loo TL, Gottlieb JA.
    Cancer Res; 1976 Feb 17; 36(2 Pt 1):511-5. PubMed ID: 1260749
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Ahmann DL, Hahn RG, Bisel HF.
    Cancer Chemother Rep; 1972 Feb 17; 56(1):93-4. PubMed ID: 5030810
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR.
    J Natl Cancer Inst; 1971 Feb 17; 46(2):359-68. PubMed ID: 4256014
    [No Abstract] [Full Text] [Related]

  • 15. "Big" insulin and the treatment of an islet cell carcinoma with streptozotocin.
    Pearson MJ, Larkins RG, Martin FI.
    Metabolism; 1972 Jun 17; 21(6):551-8. PubMed ID: 4337586
    [No Abstract] [Full Text] [Related]

  • 16. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB, Boldrey EB, Enot KJ.
    Cancer Chemother Rep; 1970 Aug 17; 54(4):273-81. PubMed ID: 4334089
    [No Abstract] [Full Text] [Related]

  • 17. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG.
    Cancer Chemother Rep; 1971 Jun 17; 55(3):303-7. PubMed ID: 5115851
    [No Abstract] [Full Text] [Related]

  • 18. [The treatment of insulinoma with streptozotocin].
    Piroska E, Kollin E.
    Orv Hetil; 1972 Feb 13; 113(7):392-4. PubMed ID: 4334607
    [No Abstract] [Full Text] [Related]

  • 19. Structure-activity relationships: nitrosoureas.
    Johnston TP.
    Cancer Chemother Rep 3; 1972 May 13; 3(1):50-1. PubMed ID: 5065660
    [No Abstract] [Full Text] [Related]

  • 20. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK, Newman JW.
    Cancer Chemother Rep 3; 1968 Dec 13; 1(1):115-51. PubMed ID: 4917773
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.